Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.2K Buy
234
+2
+0.9% +$166 ﹤0.01% 421
2026
Q2
$15.6K Buy
232
+85
+58% +$5.66K ﹤0.01% 479
2026
Q1
$9.23K Buy
147
+70
+91% +$4.88K ﹤0.01% 588
2025
Q4
$5.11K Buy
77
+47
+157% +$3.04K ﹤0.01% 567
2025
Q3
$2.02K Buy
+30
New +$2.37K ﹤0.01% 721

Other funds holding DXCM

James T. Borello RIA's DXCM Position: Q3 2026 in Review

James T. Borello RIA increased its DexCom (DXCM) stake by 0.86% in Q3 2026, buying an estimated $166 and bringing the position to 234 shares worth $20.2K. The position accounts for ﹤0.01% of the portfolio, ranked #421.

James T. Borello RIA first reported a position in DXCM in Q3 2025 and has held it in 5 quarters since. 135 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • James T. Borello RIA held 234 shares of DexCom worth $20.2K as of Q3 2026.
  • James T. Borello RIA bought 2 DexCom shares in Q3 2026, an estimated $166.
  • DexCom made up ﹤0.01% of James T. Borello RIA's portfolio in Q3 2026, its #421 holding.
  • James T. Borello RIA first reported a position in DexCom in Q3 2025 and has held it in 5 quarters since.
  • 135 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on James T. Borello RIA's 13F filing for Q3 2026, filed 16 Oct 2026.